Dramatic efficacy of infliximab in cauda equina syndrome complicating ankylosing spondylitis

Arthritis and Rheumatism

Volumn 60, Issue 6, 2009, Pages 1657-1660

  Cornec, Divi ^a   Pensec, Valérie Devauchelle ^a   Joulin, Sandrine Jousse ^a   Saraux, Alain ^a,b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; CAUDA EQUINA SYNDROME; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG EFFICACY; FECES INCONTINENCE; HUMAN; HYPESTHESIA; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POLYRADICULOPATHY; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66449088821     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24597     Document Type: Article

References (15)

1. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-1227
2. Westerveld LA, Verlaan JJ, Oner FC. Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications. Eur Spine J 2009;18:145-156
3. Bowie E, Glasgow G. Cauda equina lesions associated with ankylosing spondylitis: report of three cases. Br Med J 1961;2:24-27
4. Ahn NU, Ahn UM, Nallamshetty L, Springer BD, Buchowski JM, Funches L, et al. Cauda equina syndrome in ankylosing spondylitis (the CES-AS syndrome): meta-analysis of outcomes after medical and surgical treatments. J Spinal Disord 2001;14:427-433 (Pubitemid 32946147)
5. Arslanoglu A, Aygun N. Magnetic resonance imaging of cauda equina syndrome in long-standing ankylosing spondylitis. Australas Radiol 2007;51:375-377 (Pubitemid 47052686)
6. Miller R, Bartolo DC, Locke-Edmunds JC, Mortensen NJ. Prospective study of conservative and operative treatment for faecal incontinence. Br J Surg 1988;75:101-105 (Pubitemid 18078519)
7. Soeur M, Monseu G, Baleriaux-Waha D, Duchateau M, Williame E, Pasteels JL. Cauda equina syndrome in ankylosing spondylitis: anatomical, diagnostic, and therapeutic considerations. Acta Neurochir (Wien) 1981;55:303-315 (Pubitemid 11114860)
8. Confavreux C, Larbre JP, Lejeune E, Sindou M, Aimard G. Cerebrospinal fluid dynamics in the tardive cauda equina syndrome of ankylosing spondylitis. Ann Neurol 1991;29:221-223
9. Dinichert A, Cornelius JF, Lot G. Lumboperitoneal shunt for treatment of dural ectasia in ankylosing spondylitis. J Clin Neurosci 2008;15:1179-1182
10. Hauge T. Chronic rheumatoid polyarthritis and spondylarthritis associated with neurological symptoms and signs occasionally simulating an intraspinal expansive process. Acta Chir Scand 1961;120:395-401.
11. Bilgen IG, Yunten N, Ustun EE, Oksel F, Gumusdis G. Adhesive arachnoiditis causing cauda equina syndrome in ankylosing spondylitis: CT and MRI demonstration of dural calcification and a dorsal dural diverticulum. Neuroradiology 1999;41:508-511 (Pubitemid 29348668)
12. Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH. Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother 2003;37:1256-1265 (Pubitemid 37040219)
13. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-1193 (Pubitemid 34304258)
14. Braun J, Landewe R, Hermann KA, Han J, Yan S, Williamson P, et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006;54:1646-1652
15. Braun J, Deodhar A, Dijkmans B, Geusens P, Sieper J, Williamson P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Arthritis Rheum 2008;59:1270-1278